MARY HARKINS: Open Payments
NPI 1033419809 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,752 in 189 payments from 40 companies in 2025. Trend: 2023 $110 · 2024 $1,249 · 2025 $3,752
Food & beverage: $3,652Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $449 |
| Janssen Biotech, Inc. | 22 | $350 |
| Novartis Pharmaceuticals Corporation | 18 | $300 |
| Incyte Corporation | 20 | $276 |
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $191 |
| Merck Sharp & Dohme LLC | 8 | $154 |
| Daiichi Sankyo Inc. | 7 | $145 |
| BeOne Medicines USA, Inc. | 6 | $115 |
| Karyopharm Therapeutics Inc. | 6 | $109 |
Products named: Vyloy, JAKAFI, TECVAYLI, KEYTRUDA, ICLUSIG, XPOVIO, Doptelet, Vanflyta.
Industry payments across MS — which companies pay providers there.
